1 01/02/2025 31/01/2026 2026-01-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2025-02-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 11759544 2025-02-01 2026-01-31 11759544 2026-01-31 11759544 2025-01-31 11759544 2024-02-01 2025-01-31 11759544 2025-01-31 11759544 2024-01-31 11759544 bus:RegisteredOffice 2025-02-01 2026-01-31 11759544 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 11759544 bus:Director1 2025-02-01 2026-01-31 11759544 core:WithinOneYear 2026-01-31 11759544 core:WithinOneYear 2025-01-31 11759544 bus:Micro-entities 2025-02-01 2026-01-31 11759544 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 11759544 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 11759544 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 11759544 bus:FullAccounts 2025-02-01 2026-01-31
Company registration number: 11759544
VEEPHARM LIMITED
Unaudited filleted financial statements
31 January 2026
VEEPHARM LIMITED
Contents
Directors and other information
Statement of financial position and notes to the financial statements
VEEPHARM LIMITED
Directors and other information
Director Vaishali Ghai
Company number 11759544
Registered office 19 Falcon Avenue
South Ockendon
Essex
RM15 5FQ
Business address 19 Falcon Avenue
South Ockendon
Essex
RM15 5FQ
Accountants Xeinadin London Limited
19-20 Bourne Court
Southend Road
Woodford Green
Essex
IG8 8HD
VEEPHARM LIMITED
Statement of financial position
31 January 2026
2026 2025
£ £ £ £
Fixed assets 1,114 1,486
_______ _______
Current assets 6,396 5,799
Prepayments and accrued income 1,092 -
_______ _______
7,488 5,799
Creditors: amounts falling due within one year ( 7,359) ( 6,450)
_______ _______
Net current assets/(liabilities) 129 ( 651)
_______ _______
Total assets less current liabilities 1,243 835
Accruals and deferred income ( 900) ( 600)
_______ _______
Net assets 343 235
_______ _______
Capital and reserves 343 235
_______ _______
Notes to the financial statements
VEEPHARM LIMITED
Year ended 31 January 2026
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
2. Directors advances, credits and guarantees
There are no directors advance during the year ended 31 January 2026.
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 27 October 2026 , and are signed on behalf of the board by:
Vaishali Ghai
Director
Company registration number: 11759544
The company is a private company limited by shares, registered in England and wales.